Buffett is building up his cash. Should we be worried?
Investing in stock markets driven by Wall Street can be akin to the dark arts, so let’s see if this Buffett revelation is a spooky omen.
Monday Edition, 25 November 2024
Amcor nabs Berry, but is it a buy?
Let’s take a closer look at packaging giant Amcor (AMC) acquiring US consumer packaging business Berry Global Group. What do the brokers say? What’s the bottom line? And what do I think?
“HOT” stock 1: Sonic Healthcare (SHL),
In our “HOT” stock column today, Raymond Chan, Head of Asian Desk, explains why Morgans continues to see Sonic Healthcare (SHL) as an ADD to an investor’s portfolio.
3 Aussie stocks leveraging into big global opportunities
Here are three Australian stocks in very different industries leveraging into big global market opportunities.
Buy, Hold & Sell, What the Brokers Say…
FNArena recorded thirteen upgrades and nine downgrades for ASX-listed companies by brokers monitored daily.
SwitzerTV Monday 25th November 2024
Buffett is cashing up, should you? And we look at PDN, A2M, CBA, IEL, lithium stocks and more
Switzer on Saturday, 23 November 2024
Why is this Trump tailwind so strong?
Another post-Trump win for Wall Street but there has been a notable difference, with the real world winning over the unreal tech world.
Thursday Edition, 21 November 2024
The rallying greenback is a trading opportunity and portfolio risk
Here are two exchange traded fund strategies to manage short- and long-term exposures to the US dollar.
“HOT” stock: Goodman Group (GMG)
In our “HOT” stock column, Michael Gable, Managing Director of Fairmont Equities, explains why at these levels Goodman Group (GMG) is a buying opportunity.
Questions of the Week
What do you make of Amcor’s merger with Berry? Will this be good for Amcor’s share price? Is there an ETF that invests in bank bonds and other low risk, higher income securities? What do the brokers think of Brambles, which has recently hit an all-time high? When is CUSCAL expected to start trading on the ASX?
Boom! Doom! Zoom! | 21st November 2024
Peter Switzer & Paul Rickard answer your questions on CSL, SEK, BHP & more
Monday Edition, 18 November 2024
Let’s put Perpetual (PPT) and Corporate Travel Management (CTD) under the microscope
At a conference last week, Perpetual and Corporate Travel Management were tipped to investors. I’ve checked out what the analysts think of these two stocks and then given you my view below.
Can Xero continue to be a shining star?
Last Thursday, Xero delivered its first half result, and the market loved it, sending its share price 7% higher and closing the week at $172.61. Xero continues to see significant growth opportunities. Here’s what I think of this accounting software provider.
“HOT” stock: Aristocrat Leisure’s (ALL)
In our “HOT” stock column today, Raymond Chan, Head of Asian Desk, Morgans explains why Aristocrat Leisure's (ALL) is seen as an ADD to an investor’s portfolio.
3 medical devices ‘stars’
Here are three smaller companies on the ASK that are advancing their device products in a very promising manner and hoping to emulate the examples of Cochlear and ResMed.